Selinexor for multiple myeloma receives accelerated FDA approval
by H. Lee Moffitt Cancer Center & Research InstituteMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0A first-in-class d
Updated on: May 09,2024
4

Selinexor for multiple myeloma receives accelerated FDA approval
by H. Lee Moffitt Cancer Center & Research InstituteMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0A first-in-class d
Updated on:May 09,2024
4
